Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Nathrath

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Gastroenterology|January 15, 2014
Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel diseaseYaron Avitzur, Conghui Guo, Lucas A Mastropaolo, et al.
Clinical Sarcoma Research|June 18, 2016
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop ReportLeo Kager, Jeremy Whelan, Uta Dirksen, et al.
Gastroenterology|December 31, 2022
Constitutional Microsatellite Instability, Genotype, and Phenotype Correlations in Constitutional Mismatch Repair DeficiencyRichard Gallon, Rachel Phelps, Christine Hayes, et al.
Leukemia|August 22, 2019
Genotyping circulating tumor DNA of pediatric Hodgkin lymphomaAnn-Kathrin Desch, Kristin Hartung, Ante Botzen, et al.
NPJ Precision Oncology|December 27, 2022
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORMHeike Peterziel, Nora Jamaladdin, Dina ElHarouni, et al.
The Lancet. Oncology|June 27, 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialSelim Corbacioglu, Holger Lode, Susanne Ellinger, et al.
Cancer Research|July 8, 2022
FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional CircuitsJessica W Tsai, Paloma Cejas, Dayle K Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|August 2, 2016
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot studyBarbara C Worst, Cornelis M van Tilburg, Gnana Prakash Balasubramanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2024
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium StatementDarrell Green, Roelof van Ewijk, Elisa Tirtei, et al.
The Lancet. Oncology|August 30, 2016
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trialNeyssa M Marina, Sigbjørn Smeland, Stefan S Bielack, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Gastroenterology|January 15, 2014
Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel diseaseYaron Avitzur, Conghui Guo, Lucas A Mastropaolo, et al.
Clinical Sarcoma Research|June 18, 2016
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop ReportLeo Kager, Jeremy Whelan, Uta Dirksen, et al.
Gastroenterology|December 31, 2022
Constitutional Microsatellite Instability, Genotype, and Phenotype Correlations in Constitutional Mismatch Repair DeficiencyRichard Gallon, Rachel Phelps, Christine Hayes, et al.
Leukemia|August 22, 2019
Genotyping circulating tumor DNA of pediatric Hodgkin lymphomaAnn-Kathrin Desch, Kristin Hartung, Ante Botzen, et al.
NPJ Precision Oncology|December 27, 2022
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORMHeike Peterziel, Nora Jamaladdin, Dina ElHarouni, et al.
The Lancet. Oncology|June 27, 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialSelim Corbacioglu, Holger Lode, Susanne Ellinger, et al.
Cancer Research|July 8, 2022
FOXR2 Is an Epigenetically Regulated Pan-Cancer Oncogene That Activates ETS Transcriptional CircuitsJessica W Tsai, Paloma Cejas, Dayle K Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|August 2, 2016
Next-generation personalised medicine for high-risk paediatric cancer patients - The INFORM pilot studyBarbara C Worst, Cornelis M van Tilburg, Gnana Prakash Balasubramanian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2024
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium StatementDarrell Green, Roelof van Ewijk, Elisa Tirtei, et al.
The Lancet. Oncology|August 30, 2016
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trialNeyssa M Marina, Sigbjørn Smeland, Stefan S Bielack, et al.
Pageof 9